| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| vemurafenib melanoma | 0.08 | 1 | 4120 | 7 | 20 |
| vemurafenib | 1.19 | 0.1 | 4101 | 2 | 11 |
| melanoma | 1.94 | 0.4 | 2396 | 64 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| vemurafenib melanoma | 1.75 | 0.6 | 4318 | 31 |
| vemurafenib melanoma nice | 1.16 | 0.3 | 1841 | 22 |
| atezolizumab cobimetinib vemurafenib melanoma | 0.22 | 0.9 | 9292 | 62 |
| atezolizumab immunotherapy for melanoma | 0.98 | 0.2 | 7347 | 4 |
| atezolizumab + bevacizumab | 0.47 | 0.9 | 6926 | 8 |
| atezolizumab bevacizumab fiche patient | 0.82 | 0.9 | 9883 | 23 |
| atezolizumab+bev | 1.75 | 0.1 | 2145 | 54 |
| atezolizumab in combination with bevacizumab | 0.63 | 0.7 | 2403 | 15 |
| bc cancer atezolizumab bevacizumab | 1.92 | 0.9 | 3007 | 51 |
| atezolizumab und bevacizumab nebenwirkungen | 0.82 | 0.6 | 1267 | 48 |
